Prognostic Significance of CK5/6 and GATA3 Expression in Recurrent Urothelial Carcinoma
1. CK5/6 and GATA3 in UCa recurrences may differ from CK5/6 and GATA3 expression in primary UCa. Intensified oncological surveillance is suggested for patients with recurrent CK5/6(+) 2. Patients with at least one UCa CK5/6(-) recurrence have better prognosis compared to patients with only CK5/6(+) recurrences.
Authors
- Marzena Lenda-Petrykowska
- Krzysztof Safranow (ORCID: https://orcid.org/0000-0001-9415-2758)
- Violetta Sulżyc‐Bielicka (ORCID: https://orcid.org/0000-0001-7542-1414)
- Jerzy Świtała
- W Dobrzycki
- Dorota Kostrzewa‐Nowak (ORCID: https://orcid.org/0000-0001-7025-3087)
- Paweł Bielicki
Institutions
- University of Szczecin (PL)
- Pomeranian Medical University (PL)
Publication Details
- Journal
- Cancers
- Published
- 2025-10-09
- DOI
- https://doi.org/10.3390/cancers17193267
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00